Intarcia Therapeutics, Inc.
Records under this name other than the patents Intarcia Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 27 patents it holds.
Back to Intarcia Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,042,557 | Rapid Establishment And/Or Termination of Substantial Steady-State Drug Delivery now held by I2O Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 11,840,559 | Glucagon-Receptor Selective Polypeptides and Methods of Use Thereof now held by I2O Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 12,122,816 | Long Acting Peptide Tyrosine Tyrosine (PYY) Analogs and Methods of Use now held by I2O Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 12,084,485 | Long Acting Glucagon Like POLYPEPTIDE-1 (GLP-1) Receptor Agonists and Methods of Use now held by I2O Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 12,018,059 | Human Amylin Analog Polypeptides and Methods of Use now held by I2O Therapeutics, Inc. In force · High confidence | In force | High confidence | |
| US 8,801,700 | Osmotic Delivery Systems and Piston Assemblies for Use Therein Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 8,114,430 | Polyoxaester Suspending Vehicles for Use with Implantable Delivery Systems Term ended Term ended Mar 13, 2026 · High confidence | Term ended | Term ended Mar 13, 2026 | High confidence |
| US 7,655,254 | Implantable Device for Continuous Delivery of Interferon Term ended Term ended Feb 3, 2026 · High confidence | Term ended | Term ended Feb 3, 2026 | High confidence |
| US 8,158,150 | Two-Piece, Internal-Channel Osmotic Delivery System Flow Modulator Term ended Term ended Feb 3, 2026 · High confidence | Term ended | Term ended Feb 3, 2026 | High confidence |
| US 8,206,745 | Solvent/Polymer Solutions as Suspension Vehicles Term ended Term ended Feb 3, 2026 · High confidence | Term ended | Term ended Feb 3, 2026 | High confidence |